Search results
Results from the WOW.Com Content Network
(Reuters) -AbbVie on Tuesday said Chief Operating Officer Robert Michael would succeed Richard Gonzalez to become the second-ever CEO of the drugmaker on July 1. Gonzalez, 70, who has been at the ...
On June 1, 2024, AbbVie's current President and Chief Operating Officer (COO) Robert Michael replaced Richard Gonzalez as CEO of AbbVie. Gonzalez will be the executive chairman. [38] In February 2024, AbbVie Inc. and Tentarix Biotherapeutics announced the beginning of a long-term collaboration in the discovery and development of opportunistic ...
Chairman of the Board and CEO of Abbvie Inc (30-Year Financial, Insider Trades) Richard A Gonzalez (insider trades) sold 231,604 shares of ABBV on 11/12/2020 at an average price of $96.88 a share.
AbbVie also replaced its leader as CEO Richard Gonzalez stepped down; Gonzalez had been at the helm since 2013. ... AbbVie's current lineup should allow it to perform well in the medium term ...
After the split, Miles White will remain chairman and CEO of Abbott while Rick Gonzalez, current VP of pharmaceutical products, will take over as AbbVie's chairman and CEO. White has held his post ...
He dropped out of school and worked as a laborer before being hired at the age of 18 as a janitor for Frito-Lay, at its Rancho Cucamonga factory, in 1976. [ 6 ] [ 1 ] According to records at Frito-Lay, Montañez was promoted to a machinist operator position by October 1977, [ 2 ] and was a senior machinist operator in autumn 1993.
He was elected to the Board of Directors in April 1998, to CEO in 1999, [6] and to Chairman of the Board in April 1999. [1] [5] As of November 2019, White's tenure is the second longest for a non-founder CEO among the S&P 100. Under his leadership, he has created approximately $200 billion in shareholder value. [7]
AbbVie's top executives answer tough questions about the company's products and pipeline.